Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|May 1, 2003
Topical Retinoid Comparisons
San Francisco -- Results of a comparative clinical trial indicate there are marked differences in the cumulative irritation potential of marketed topical retinoids, Judit Nyirady, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
4
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
5